Sugi Predict

Sugi Predict / Compounds / SCHEMBL25517909

SCHEMBL25517909

SCHEMBL25517909

CCOP(=O)(CC[C@H]1O[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 4/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ THRB P10828 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ PPARD Q03181 1/20 0.37
▸ OGA O60502 1/20 0.36
▸ NR3C1 P04150 1/20 0.35
▸ FYN P06241 1/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ ADRA2B P18089 1/20 0.35
▸ DRD4 P21917 1/20 0.35
▸ DRD3 P35462 1/20 0.35
▸ P4HB P07237 1/20 0.35
▸ PDIA4 P13667 1/20 0.35
▸ PDIA3 P30101 1/20 0.35
▸ CA12 O43570 3/20 0.33
▸ CA1 P00915 3/20 0.33
▸ CA9 Q16790 3/20 0.33
▸ BCHE P06276 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25495689 1.00 CA2 (0.41) CA2CYP2D6THRBHSD17B10PPARD
SCHEMBL22614597 0.99 CA2 (0.40) CA2CYP2D6THRBHSD17B10PPARD
SCHEMBL25516359 0.92 CA2 (0.40) CA2CYP2D6THRBHSD17B10PPARD
SCHEMBL25496355 0.87 CYP2D6 (0.35) CA2CYP2D6THRBHSD17B10PPARD
SCHEMBL25495548 0.87 CYP2D6 (0.35) CA2CYP2D6THRBHSD17B10PPARD
SCHEMBL25495865 0.87 PPARD (0.35) CA2CYP2D6THRBHSD17B10PPARD
SCHEMBL25496257 0.87 PPARD (0.35) CA2CYP2D6THRBHSD17B10PPARD
SCHEMBL25496078 0.87 PPARD (0.35) CA2CYP2D6THRBHSD17B10PPARD
SCHEMBL25495547 0.86 PPARD (0.37) CA2CYP2D6THRBHSD17B10PPARD
SCHEMBL25495692 0.86 PPARD (0.37) CA2CYP2D6THRBHSD17B10PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651903-A1 M6PR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
EP-4651901-A1 CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
WO-2025035040-A1 LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF MUSCLE-SPECIFIC KINASE AUTOANTIBODIES LYCIA THERAPEUTICS, INC. (US) 2025-02-13 — — WO disclosed
WO-2024155748-A1 M6PR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
EP-4370156-A1 M6PR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2024-05-22 — — EP disclosed
US-20230158155-A1 Cell Surface Receptor Binding Compounds and Conjugates LYCIA THERAPEUTICS, INC. 2023-05-25 — — US disclosed
WO-2023288015-A1 M6PR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2023-01-19 — — WO disclosed
EP-4087584-A2 CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2022-11-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158155-A1 Cell Surface Receptor Binding Compounds and Conjugates M6PR, ASGR1, IGF2R CA2 3060/4885CYP2D6 2202/4885THRB 1793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.